Man Li
Impact in
- Pharmaceutical Science top 0.5%
- Fluorine in Organic Chemistry
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 36
-
- Nanoplatforms for cancer theranostics 49
- Co-authors
- Zhirong Zhang (50 shared papers)Qin He (59 shared papers)Xiao‐Song Xue (10 shared papers)Xun Sun (12 shared papers)Jin‐Pei Cheng (9 shared papers)Tao Gong (10 shared papers)Xian Tang (19 shared papers)Qianwen Yu (17 shared papers)
- Journals
- Journal of Controlled Release (20 papers)Acta Biomaterialia (12 papers)ACS Applied Materials & Interfaces (9 papers)International Journal of Pharmaceutics (7 papers)Nanoscale (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Man Li
340 papers receiving 9.7k citations
Man Li's Hit Papers
Peers
Comparison fields: 5 of 178
- Pharmaceutical Science 756
- Biomaterials 1.5k
- Immunology 1.8k
- Oncology 1.9k
- Cancer Research 1.0k
Countries citing papers authored by Man Li
This map shows the geographic impact of Man Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Li more than expected).
Fields of papers citing papers by Man Li
This network shows the impact of papers produced by Man Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Li. The network helps show where Man Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Man Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 354 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 214 | |
| 2 | Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer Hit paper breakdown → | 2021 | 195 |
| 3 | 2017 | 193 | |
| 4 | 2020 | 174 | |
| 5 | 2016 | 171 | |
| 6 | 2015 | 161 | |
| 7 | 2016 | 157 | |
| 8 | 2017 | 140 | |
| 9 | 2016 | 131 | |
| 10 | 2014 | 117 | |
| 11 | 2017 | 113 | |
| 12 | 2017 | 113 | |
| 13 | 2015 | 110 | |
| 14 | 2019 | 108 | |
| 15 | 2020 | 107 | |
| 16 | 2019 | 106 | |
| 17 | 2020 | 105 | |
| 18 | 2019 | 103 | |
| 19 | 2020 | 101 | |
| 20 | 2019 | 89 |
About Man Li
Man Li is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Immunology and Biomaterials, having authored 354 papers that have together received 9.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (49 papers), Nanoparticle-Based Drug Delivery (37 papers), RNA Interference and Gene Delivery (36 papers), Immunotherapy and Immune Responses (25 papers), Immune cells in cancer (22 papers), Immune Cell Function and Interaction (17 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Autophagy in Disease and Therapy (14 papers). The work is most often cited by research in Pharmaceutical Science (756 citations), Biomaterials (1.5k citations), Immunology (1.8k citations), Oncology (1.9k citations) and Cancer Research (1.0k citations). Man Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhirong Zhang, Qin He, Xiao‐Song Xue, Xun Sun, Jin‐Pei Cheng, Tao Gong, Xian Tang, Qianwen Yu, Yang Long and Zhengze Lu. Their work appears in journals such as Journal of Controlled Release, Acta Biomaterialia, ACS Applied Materials & Interfaces, International Journal of Pharmaceutics and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.